Meet Zest Heath at AMCP Nexus
Specialty dermatology spend is unmanaged, and it's growing fast. We’re gathering with leaders in managed care pharmacy to change the paradigm of dermatology care through deprescribing at scale, without sacrificing outcomes.
Speakers & Presenters
Frannie McGowan, PharmD
Chief Growth Officer
Spotlight Session
The Hidden Lever: Addressing rising dermatology spend
Rachel Day, MD, FAAD
Chief Medical Officer
Silver Awarded Poster Presentation
Medicare Part D formulary design for high-cost dermatology biologics
Why Value-Based Dermatology
Slash Unnecessary Biologic Spend in Half
Unmanaged spend, meet reassessment
Dermatology biologics are among the fastest-growing specialty categories — up 46% in net trend. Zest deprescribes 50%+ of enrolled members without compromising outcomes.
Remission-centered, not “set it and forget it”
The right drug at the right time — treatment optimizes as disease improves, instead of renewing on autopilot.
Paid on outcomes, not visits
Risk- and value-based contracts keep Zest's incentives aligned with yours.
Built on formulary, not around it
Evidence-based deprescribing protocols that are validated against national and international consensus criteria — so they hold up with your P&T committee, not just your finance team.
The Hidden Lever: Addressing Rising Dermatology Spend
Wednesday, Oct. 28 at 9:30AM PT • Expo Hall
Frannie McGowan, PharmD, presents a spotlight session on the intersection of clinical outcomes and drug spend. This spotlight shares the clinical case and presents how to operationalize it at scale.
Longitudinal Analysis of Medicare Part D Formulary Design for High-Cost Dermatology Systemics
Tuesday, Oct. 27 from 4:30-5:30pm
Wednesday, Oct. 28 from 12-1pm • Expo Hall
Rachel Day, MD, FAAD, presents silver awarded poster on how formulary structure shapes access to psoriasis and eczema biologics for Medicare Part D populations — and what health plans can do to right-size it.
How Zest Works
Remission-First, Value-Based Dermatology Care
Members book online and see a dermatology specialist virtually within days, no matter where they are. No long waits, no waiting rooms, and no prescriptions renewed on autopilot without a clinician actually looking at the case.
Zest's model identifies members who are on the wrong treatment plan for where they are today — deprescribing over 50% of enrolled patients without compromising disease control.
Treatment isn't limited to a single script. Zest's clinicians combine topicals, immunomodulators, biologics, and phototherapy with whole-person guidance — nutrition, stress management, and skin care routines — built around what each member's skin actually needs.
Case Study
Working With Health Plans to Reduce Costs
Get in Touch
Let's work together to deliver higher-quality, lower cost dermatology care to your population.
Zest is committed to helping your organization reduce costs and improve care outcomes. Book time with our team at AMCP Nexus to learn how a partnership with Zest Health can support your goals.
By submitting the form, I agree to Zest's Terms and Policies.